@Gabepluguez There is a paper out there called "Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Great paper, these drugs have been out a very long time. Yes, side effects can occur, nausea, vomiting, and pancreatitis. However there are many that do just fine on it.
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Sep 2024 – Dec 2025Where it's discussed
-
News28 articles
-
Blogs4 articles
-
X / Twitter3 posts
-
Facebook3 posts
-
YouTube2 videos
AI synopsis
What people are saying
Several comments express a general acknowledgment of the article’s importance, such as noting that GLP-1 drugs have been available for a long time, indicating familiarity and recognition. The tone further reveals interest by discussing side effects like nausea and pancreatitis, which shows participants are engaged with practical concerns, though the impact is seen as moderate since the discussion mainly reinforces known information rather than urging immediate or widespread changes.
Most discussions recognize the significance of the article, either acknowledging its thorough review or supporting its findings.
Participants show moderate curiosity, mentioning the longstanding use of GLP-1 drugs and their effects.
The conversations include references to side effects and drug efficacy, indicating a moderate level of detailed engagement.
The overall tone suggests that while the article is respected, it doesn’t seem to be viewed as dramatically transformative but rather as an important reinforcement of existing knowledge.
Abstract in brief
- The GLP-1 receptor (GLP-1R) is an important G protein-coupled receptor that interacts with the hormone GLP-1, which regulates blood sugar and lipid metabolism.
- Recent innovations in GLP-1 medications have highlighted their effectiveness and expanding applications in treating various health issues.
- The article reviews the development of GLP-1 drugs, their pharmacological properties, and their potential use in conditions like obesity, heart disease, and neurodegenerative diseases, emphasizing their therapeutic benefits.
Top posts
Most liked on X and BlueskyGlucagon-like peptide-1 receptor: mechanisms and advances in therapy https://t.co/4FMr0qTpIM
All mentions
GLP-1 Receptor Agonists and Future of Weight Management
This video explores the role of GLP-1 receptor agonists in addressing obesity and other health issues. It reviews recent innovations, their effectiveness in treating obesity, heart disease, and neurodegenerative…
Impact of Weight Loss Medications on Obesity Management and Heart Health
New weight loss drugs are trending on TikTok. This video explores their effectiveness, origins, challenges in treating obesity, and potential health risks, including associations with valvular heart disease from drugs…
Understanding GLP-1 Receptor and Its Role in Disease Treatment
@MariaJonsson1 @Dominanski Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | Signal Transduction and Targeted Therapy
@Gabepluguez There is a paper out there called "Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Great paper, these drugs have been out a very long time. Yes, side effects can occur, nausea, vomiting, and pancreatitis. However there are many that do just fine on it.
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy https://t.co/4FMr0qTpIM